目前正在每日口服暴露前预防药物（PrEP）的男男性行为者（MSM）中，获取长效注射用暴露前预防药物（LA-PrEP）的地点偏好。

Location Preferences for Accessing Long-Acting Injectable Pre-Exposure Prophylaxis (LA-PrEP) Among Men Who Have Sex With Men (MSM) Currently on Daily Oral PrEP.

作者信息

Glick Jennifer L, Nestadt Danielle F, Sanchez Travis, Li Kevin, Hannah Marissa, Rawlings M Keith, Rinehart Alex R, Sarkar Supriya, Vannappagari Vani

机构信息

Community Health Science & Policy (CHSP), Louisiana State University, Health Sciences Center, New Orleans, LA, USA.

Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

出版信息

J Int Assoc Provid AIDS Care. 2024 Jan-Dec;23:23259582241293336. doi: 10.1177/23259582241293336.

DOI:10.1177/23259582241293336

PMID:39698980

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11788811/

Abstract

We investigated men who have sex with men's (MSM) location preferences for long-acting injectable pre-exposure prophylaxis (LA-PrEP). MSM ( = 1076) who completed the 2021 American Men's Internet Survey, were currently prescribed oral PrEP, and expressed LA-PrEP interest reported location preferences for receiving LA-PrEP: healthcare provider (HCP) setting, pharmacy, or at-home. HCP settings were preferred by 60% of participants; 26% preferred home and 14% preferred pharmacy. In adjusted models, high healthcare stigma was associated with preferring pharmacy and at-home versus HCP, while high friends/family stigma was associated with preferring HCP settings versus pharmacy. Healthcare access history was associated with preference for HCP setting versus home. Being 25 to 29 or 30 to 29 years old versus 40+ was associated with preferring HCP versus home. Private insurance was associated with location preferences. Findings support the need for multiple LA-PrEP service locations to best reach MSM and highlight multiple complex factors that influence such preferences.

摘要

我们调查了男男性行为者（MSM）对长效注射用暴露前预防（LA-PrEP）的地点偏好。完成2021年美国男性互联网调查、目前正在服用口服PrEP并表示对LA-PrEP感兴趣的1076名男男性行为者报告了接受LA-PrEP的地点偏好：医疗保健提供者（HCP）机构、药房或在家中。60%的参与者更喜欢HCP机构；26%的人更喜欢在家中，14%的人更喜欢药房。在调整模型中，较高的医疗保健污名与更喜欢药房和在家中接受注射而非HCP机构相关，而较高的朋友/家庭污名与更喜欢HCP机构而非药房相关。医疗保健获取史与更喜欢HCP机构而非在家中接受注射相关。与40岁及以上相比，25至29岁或30至39岁的人更喜欢HCP机构而非在家中接受注射。私人保险与地点偏好相关。研究结果支持需要多个LA-PrEP服务地点以最好地覆盖男男性行为者，并突出了影响此类偏好的多个复杂因素。